Tolebrutinib

CAS : 1971920-73-6

Ref. 3D-FT179188

Informations sur le produit

• Nom: Tolebrutinib

Description

Tolebrutinib is an investigational drug that has been shown to have potent inhibitory activity against immune functions. This drug has a number of clinical studies in progress for the treatment of heart disease and autoimmune diseases. Tolebrutinib is being developed by Novartis as a monoclonal antibody, which binds to the target protein Bruton's tyrosine kinase and inhibits its function. The binding of tolebrutinib with the protein prevents it from phosphorylating other proteins, thereby inhibiting their function. The binding of tolebrutinib with the protein also induces reversible covalent modifications at a number of sites on the protein, which may lead to the development of resistance over time.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 455.51 g/mol
• Formule: C₂₆H₂₅N₅O₃
• Degré de pureté: Min. 95%